G. Oriji
Aug 1, 1999
Citations
0
Influential Citations
17
Citations
Quality indicators
Journal
Prostaglandins Leukotrienes and Essential Fatty Acids
Abstract
Abstract Angiotensin II (Ang II) has been shown to stimulate the release of immunoreactive endothelin (ET) from cultured bovine ECs. Also, Ang II activates phospholipase A 2 (PLA 2 ) in various tissues, resulting in the release of arachidonic acid and formation of prostaglandins. We used rat aortic endothelial cells to investigate the role of protein kinase C (PKC) in Ang II-induced release of both ET and prostacyclin (PGI 2 ). The amount of ET and PGI 2 produced were determined by radioimmunoassay. Ang II-induced the release of both ET and PGI 2 . Pretreatment with 10 −6 M of any one of the PKC inhibitors: 1-(5-isoquinolinesulfonyl) piperazine(CL), staurosporine, 1-(5-isoquinolinesulfonyl-methyl)piperazine(H7), and calphostin C blocked AII-induced release of both ET and PGI 2 . In rat aortic endothelial cells that were treated with either AII or PDBu, PKC enzyme assay showed PKC was translocated from the cytosol to the membrane which indicates activation. This suggests that PKC mediates AII-induced ET and PGI 2 release. In summary, AII activates PKC which inhibits rat aortic endothelial cells ET and PGI 2 formation, and this inhibition can be overcome by pretreatment with PKC inhibitors. Angiotensin II; endothelin; prostacyclin; 1-(5-isoquinolinemethyl) piperazine(H7); staurosporine; 1-(5-isoquinolinesulfonyl)piperazine(CL); Calphostin C; rat aortic endothelial cells.